Category | No. of effect sizes, k | No. of patients | No. of controls | Hedges g (95% CI) | Q | Heterogeneity p value | Egger regression p value* | Fail-safe N* | Sensitivity analysis, range† |
---|---|---|---|---|---|---|---|---|---|
Overall | 151 | 6226 | 6426 | −0.582 (−0.663 to −0.501)§ | 645.563 | < 0.001 | < 0.001 | 8069 | −0.589 to −0.556 |
Disorder subgroups | |||||||||
Anxiety | 47 | 1365 | 1469 | −0.360 (−0.505 to −0.215)§ | 35.358 | < 0.001 | 0.70 | 872 | −0.379 to −0.331 |
Mood | 52 | 2838 | 2882 | −0.462 (−0.593 to −0.331)§ | 0.020 | 2712 | −0.471 to −0.439 | ||
Psychotic | 41 | 1713 | 1660 | −0.952 (−1.105 to −0.800)§ | < 0.001 | 4978 | −1.011 to −0.886 | ||
Substance dependence | 11 | 310 | 415 | −0.694 (−0.982 to −0.405)§ | 0.011 | 193 | −0.716 to −0.630 | ||
Medication use‡ | 142 | 5994 | 6163 | −0.581 (−0.662 to −0.500)§ | < 0.001 | 5333 | −0.590 to −0.555 | ||
Not medicated | 82 | 3755 | 4343 | −0.471 (−0.577 to −0.365)§ | 9.893 | 0.002 | 0.009 | 5980 | −0.479 to −0.440 |
Medicated | 60 | 2239 | 1820 | −0.734 (−0.859 to −0.609)§ | 0.15 | 6624 | −0.759 to −0.675 | ||
Anxiety disorders | 44 | 1319 | 1439 | −0.330 (−0.474 to −0.186)§ | 0.37 | 678 | −0.350 to −0.300 | ||
Not medicated | 30 | 844 | 1035 | −0.334 (−0.510 to −0.158)¶ | 0.008 | 0.93 | 0.57 | 299 | −0.363 to −0.288 |
Medicated | 14 | 475 | 404 | −0.321 (−0.571 to −0.071)** | 0.38 | 63 | −0.385 to −0.300 | ||
Mood disorders | 49 | 2739 | 2784 | −0.470 (−0.560 to −0.380)§ | 0.014 | 2607 | −0.488 to −0.454 | ||
Not medicated | 29 | 2008 | 2182 | −0.360 (−0.472 to −0.249)§ | 10.332 | 0.001 | 0.41 | 628 | −0.395 to −0.328 |
Medicated | 20 | 731 | 602 | −0.668 (−0.818 to −0.517)§ | 0.31 | 651 | −0.710 to −0.641 | ||
Psychotic disorders | 40 | 1692 | 1639 | −0.983 (−1.196 to −0.770)§ | < 0.001 | 4765 | −1.013 to −0.885 | ||
Not medicated | 19 | 812 | 987 | −0.901 (−1.210 to −0.592)§ | 0.515 | 0.47 | < 0.001 | 869 | −0.939 to −0.735 |
Medicated | 21 | 880 | 652 | −1.058 (−1.353 to −0.763)§ | 0.24 | 1541 | −1.120 to −0.888 | ||
Substance dependence disorders | 9 | 244 | 301 | −0.694 (−0.897 to −0.491)§ | 0.038 | 133 | −0.744 to −0.649 | ||
Not medicated | 4 | 91 | 139 | −0.592 (−0.907 to −0.277)¶ | 0.684 | 0.41 | 0.16 | 15 | −0.731 to −0.465 |
Medicated | 5 | 153 | 162 | −0.766 (−1.032 to −0.501)§ | 0.006 | 53 | −0.906 to −0.686 |
CI = confidence interval; HRV = heart rate variability.
↵* Tests of publication bias conducted for the overall group of studies as well as for subgroups, p value 2-tailed.
↵† Sensitivity analyses conducted using 1 study removed.
↵‡ Current medication use not stated in 9 studies, which were thus were removed from medication subgroup analyses. “Not medicated” indicates patients who were either medication-free or medication-naive at time of physiological testing.
↵§ p < 0.0001, 2-tailed.
↵¶ p < 0.001, 2-tailed.
↵** p < 0.01, 2-tailed.